Observational studyMedicine2026
Association between gut microbiota and chronic diseases in East Asian ethnicity: A two-sample Mendelian randomization study.
Observational study in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The etiology and pathogenesis of chronic diseases (CDs) are complex and may result in a variety of symptoms that negatively affect patients' daily lives. There is growing evidence that changes in the composition and function of the gut microbiota (GM) are linked to the onset and progression of CDs, but a causal relationship between them has not yet been demonstrated in the East Asian ethnicity. We sourced data from publicly available genome-wide association study summary statistics that focused on the composition of the GM and its association with 6 specific CDs: chronic obstructive pulmonary disease (COPD), Graves disease (GD), interstitial lung disease (ILD), periodontal disease (PD), peripheral arterial disease (PAD), and coronary artery disease (CAD). We then investigated the causal relationship between the GM and the 6 CDs using a two-sample Mendelian randomization approach. To assess these causal links, we applied multiple statistical methods, including MR-Egger regression, weighted median estimation, inverse-variance weighted analysis, as well as simple and weighted mode-based approaches. Among these, the inverse-variance weighted method was selected as the primary analytical strategy. To ensure the credibility and stability of our findings, we further conducted a comprehensive set of sensitivity analyses. We found that the genus Allisonella significantly increased the risk of COPD, whereas LachnospiraceaeNK4A136group decreased the risk of COPD; Anaerotruncus increased the risk of GD, whereas Lachnospiraceae UCG004 decreased the risk of GD; Catenibacterium and Bifidobacterium increased the risk of ILD, while Butyricicoccus decreased the risk of ILD; Catenibacterium and Olsenella increased the risk of PD, whereas Anaerostipes, LachnospiraceaeGroupNK4A136, Hungatella, and Lactococcus reduced the risk of PD; Parasutterella, CandidatusSoleaferrea, and Desulfovibrio increased the risk of PAD and Paraprevotella reduced the risk of PAD; Allisonella increased the risk of CAD and Senegalimassilia decreased the risk of CAD. No significant heterogeneity or polynomial estimates were found. Our research indicates a direct causal link between 19 specific types of GM and 6 chronic illnesses within East Asian populations. This contributes fresh understanding of how the composition of GM influences the development and progression of CDs.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.